HETERO LABS LIMITED
Location
Telangana
Founded
1989-03-10
Website
Risk Signals
265 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about HETERO LABS LIMITED
Live alerts from global media, monitored by Business Radar
2023-03-02 (bloomberglaw.com)
Catalyst Sues to Block Three Copies of Firdapse, Its Cash Cow
Catalyst Pharmaceuticals Inc. alleges in three new lawsuits that copies of Firdapse proposed by Teva Pharmaceutical Industries Ltd., Lupin Ltd., and Hetero Labs Ltd. infringe six patents it licenses from Serb SA for the rare autoimmune disorder treatment, its flagship drug.
Read more
(law360.com)
Janssen Gets Third Co. To Put Off Invokana Generic
Hetero Labs Ltd. has agreed to hold off on its generic version of Janssen's diabetes medication Invokana, putting an end to patent infringement litigation in New Jersey federal court.
Read more